Last updated on August 2019

EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)


Brief description of study

The aim of the study is to investigate the safety and efficacy of empagliflozin versus placebo on top of guideline-directed medical therapy in patients with heart failure with reduced ejection fraction.

Clinical Study Identifier: NCT03057977

Find a site near you

Start Over

Kusatsu General Hospital

Shiga, Kusatsu, Japan
4.13miles
  Connect »

Uji-Tokushukai Medical Center

Kyoto, Uji, Japan
8.88miles
  Connect »